Dry Fasting — The Record

Pathway atlas · node 23 of 41

Non-homologous end joining (NHEJ)

What fasting does to this node, by modality, by system and by grade. Disconfirming evidence is reported first.

Founder's role text (READ): "Directly religates double-strand break ends without a homologous template." Founder's key components (READ): PRKDC (DNA-PKcs), XRCC6/5 (KU70/80), LIG4, XRCC4. In the recommender: No.

DRY

DRY: none located. Queries: the three dry-fast queries, plus Um Kim "Calorie restriction" "non-homologous end joining" Experimental Gerontology 2011 Ku80 rat tissues and caloric restriction PARP1 APEX1 XRCC1 polymerase beta base excision repair rat liver reversal age decline (which surfaced the NHEJ rodent work).

Disconfirming evidence, first

Graded rows, supporting

RowModalitySpecies / systemTierGradeWhat was actually measuredDirection
23.1CRMouse, C57BL/6, NHEJ reporter, 4 tissuesA1CNHEJ efficiency by GFP reporter, plus DNA-PK and SIRT6 proteinUp in all four tissues
23.2CRRat, multi-tissueA1CKu80/70, NHEJ activityUp in kidney and lung, no change in liver, fails at 24 months in testis

23.1 source, opened: Ke Z, Firsanov D, Spencer B, Seluanov A, Gorbunova V. "Short-term calorie restriction enhances DNA repair by non-homologous end joining in mice." npj Aging and Mechanisms of Disease 2020;6:9. DOI 10.1038/s41514-020-00047-2. Published 14 August 2020. (Journal name, volume and article number READ from the reference list of van Galen et al. 2026, ref 51; the article page itself gave only authors, date and DOI.) Design MEASURED: male C57BL/6 mice, 3 to 5 months old, carrying an NHEJ reporter cassette in the ROSA26 locus. 40% calorie restriction: 8.4 kcal/day, stated as 60% of the average ad libitum intake of 14.3 +/- 1.3 kcal/day. 4 weeks. Single-housed. Ad libitum controls. Assay MEASURED: reporter cassette with a GFP gene interrupted by a killer exon flanked by I-SceI sites; I-SceI cuts release the exon and successful NHEJ restores GFP. Primary cells from skin, lung, kidney and brain, transfected with pCMV-I-SceI (5 micrograms) plus pCMV-DsRed (0.1 micrograms) for normalization, Amaxa Nucleofector II, flow cytometry 3 days later, NHEJ efficiency as the GFP+ to DsRed+ ratio, triplicate transfections per primary culture. MEASURED: short-term CR significantly increased NHEJ efficiency in all four tissues vs ad libitum. DNA-PK elevated in skin, SIRT6 elevated in brain. MEASURED NEGATIVE: this is calorie restriction, not fasting. The authors speculate that intermittent fasting might give similar benefits but did not test it. No human data. The authors discuss human relevance only as a speculative point.

23.2 source, located but not opened: Um JH, et al. "Calorie restriction (CR) reduces age-dependent decline of non-homologous end joining (NHEJ) activity in rat tissues." Experimental Gerontology 2011. ScienceDirect PII S0531556511001963. Three channels refused this article: sciencedirect.com (client error), academia.edu (client error), ovid.com (not attempted after the first two refusals under channel law). Full author list, volume and pages not retrieved: retrieval debt. The pathway-level Ku80/70 result reported in 23.D1 comes from Heydari 2007 and may refer to an earlier Um paper, not this 2011 one. The two are kept distinct here and not merged. Treating them as one source would be a merge error.

Open questions

1. Zero human fasting evidence. NHEJ has never been measured in a human fasting study. PRKDC, KU70, KU80, LIG4 and XRCC4 have never been measured under any fasting modality in humans. 2. The best row in the block, 23.1, is a 4-week 40% CR mouse study whose authors explicitly declined to claim it extends to intermittent fasting. 3. Whether the "Um et al." cited by Heydari 2007 is the same work as the 2011 Experimental Gerontology paper is unresolved and is recorded as an open identifier question, not guessed.


← 22. Nucleotide excision repair (NER) All 41 nodes 24. Fanconi anemia / interstrand-crosslink repair →


dryfasting.com has been published since 2014. This evidence record was compiled on 22 November 2026. Every row names the fasting modality the study actually ran, the system it was measured in and the grade. Where no source carries a DOI or PMID the row says so rather than supplying one. Nothing is sold on this site.